These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 4010109)
1. [Coagulation and fibrinolysis system in bladder tumor. 1. Urinary FDP and fibrin deposition around the tumor]. Nagai N Nihon Hinyokika Gakkai Zasshi; 1985 Jan; 76(1):20-30. PubMed ID: 4010109 [No Abstract] [Full Text] [Related]
2. The utility of fibrin/fibrinogen degradation products in superficial bladder cancer. Tsihlias J; Grossman HB Urol Clin North Am; 2000 Feb; 27(1):39-46. PubMed ID: 10696243 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases. Kaizu K; Ito Y; Uriu K; Eto S Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397 [TBL] [Abstract][Full Text] [Related]
5. The value of urinary fibrin/fibrinogen degradation products as tumor markers in urothelial carcinoma. Jayachandran S; Unni Mooppan MM; Wax SH; Kim H J Urol; 1984 Jul; 132(1):21-3. PubMed ID: 6726955 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of urinary fibrinogen degradation products in bladder carcinoma. Alsabti EA Eur Surg Res; 1979; 11(3):185-90. PubMed ID: 510327 [TBL] [Abstract][Full Text] [Related]
7. [The investigation on early diagnosis of the bladder tumor. I: A study on urinary cytology and urinary fibrin/fibrinogen degradation products (FDP) assay in patient with bladder tumor (author's transl)]. Tanahashi T Nihon Hinyokika Gakkai Zasshi; 1979 May; 70(5):553-62. PubMed ID: 470263 [No Abstract] [Full Text] [Related]
9. [The investigation on early diagnosis of the bladder tumor. II: A study on urinary cytology, urinary fibrin/fibrinogen degradation products, tissue fibrin deposition and tissue plasminogen activator activity in patients with bladder tumors (author's transl)]. Tanahashi T Nihon Hinyokika Gakkai Zasshi; 1980 Sep; 71(9):1047-54. PubMed ID: 7193258 [No Abstract] [Full Text] [Related]
10. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases]. Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281 [TBL] [Abstract][Full Text] [Related]
11. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases. Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315 [TBL] [Abstract][Full Text] [Related]
12. A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer. Schmetter BS; Habicht KK; Lamm DL; Morales A; Bander NH; Grossman HB; Hanna MG; Silberman SR; Butman BT J Urol; 1997 Sep; 158(3 Pt 1):801-5. PubMed ID: 9258086 [TBL] [Abstract][Full Text] [Related]
13. A correlative study on urinary cytology and FDP with cystoscopy and pathology in the urinary bladder cancers. Tanahashi T; Matsumura Y; Ohmori H; Tanaka T Acta Med Okayama; 1978 Jun; 32(2):139-46. PubMed ID: 150199 [TBL] [Abstract][Full Text] [Related]
14. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases]. Shibata K; Dohi K; Fujii Y; Ishikawa H Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632 [TBL] [Abstract][Full Text] [Related]
15. Role of intrarenal coagulation and anticoagulant therapy in the progression of diabetic nephropathy. Kaizu K; Uriu K; Hashimoto O; Morita E; Eto S; Suzuki H Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):35-42. PubMed ID: 8336398 [TBL] [Abstract][Full Text] [Related]
16. Evidence that fibrin(ogen) degradation products (FDP) are adequately quantified in citrated plasma defibrinated at low pH. Godal HC; Hamborg T Scand J Haematol; 1984 Jan; 32(1):46-8. PubMed ID: 6695150 [TBL] [Abstract][Full Text] [Related]
17. Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systems. Hunt FA; Rylatt DB; Hart RA; Bundesen PG Br J Haematol; 1985 Aug; 60(4):715-22. PubMed ID: 3896298 [TBL] [Abstract][Full Text] [Related]
18. Fibrin deposits in the glomeruli and fibrin/fibrinogen degradation products (FDP) in the blood and urine in some renal diseases. Tishkov I; Tschoukanov C; Doytshinov D; Shipkova P Int Urol Nephrol; 1982; 14(1):89-93. PubMed ID: 7118491 [TBL] [Abstract][Full Text] [Related]
19. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays. Arnesen H J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131 [No Abstract] [Full Text] [Related]
20. [Clinical investigations on urinary fibrinolysis in bladder carcinoma (author's transl)]. Ueda S; Hirayama H; Arita M; Ikegami K Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1241-6. PubMed ID: 732059 [No Abstract] [Full Text] [Related] [Next] [New Search]